State Meeting Reveals Upcoming EDL Drug Policies
This article was originally published in PharmAsia News
Executive Summary
China’s recent inter-provincial centralized drug procurement exchange conference indicated future pressure on off-patent drug prices and that authorities may use international certification in generic essential drug quality classification.